Stage IA Breast Cancer Active Not Recruiting Phase 3 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00005970Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerTreatment
NCT01275677Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerTreatment
NCT00433511Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerTreatment